Immunological Effect of Neoadjuvant Chemoradiotherapy on Tumor Microenvironment of Pancreatic Cancer

被引：0
|
作者：
Homma, Y. [1 ]
Taniguchi, K. [1 ]
Matsuyama, R. [1 ]
Murakami, T. [1 ]
Nakagawa, K. [1 ]
Mori, R. [1 ]
Nojiri, K. [1 ]
Kumamoto, T. [1 ]
Ueda, M. [1 ]
Takeda, K. [1 ]
Ichikawa, Y. [1 ]
Tanaka, K. [1 ]
Endo, I. [1 ]
机构：
[1] Yokohama City Univ, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan
来源：
PANCREAS | 2012年 / 41卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1154 / 1154
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [22] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    Updates in Surgery, 2016, 68 : 235 - 239
  • [23] The Role of Neoadjuvant Chemoradiotherapy for Potentially Resectable Pancreatic Cancer
    Kim, Yoon Jae
    Choi, Jin-Young
    Chung, Yong Eun
    Kim, Hee Man
    Park, Semi
    Kim, Hong Jeoung
    Hong, Sung Pil
    Seong, Jinsil
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Bang, Seungmin
    GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
  • [24] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [25] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Yuki Homma
    Koichi Taniguchi
    Takashi Murakami
    Kazuya Nakagawa
    Masatoshi Nakazawa
    Ryusei Matsuyama
    Ryutaro Mori
    Kazuhisa Takeda
    Michio Ueda
    Yasushi Ichikawa
    Kuniya Tanaka
    Itaru Endo
    Annals of Surgical Oncology, 2014, 21 : 670 - 676
  • [26] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Homma, Yuki
    Taniguchi, Koichi
    Murakami, Takashi
    Nakagawa, Kazuya
    Nakazawa, Masatoshi
    Matsuyama, Ryusei
    Mori, Ryutaro
    Takeda, Kazuhisa
    Ueda, Michio
    Ichikawa, Yasushi
    Tanaka, Kuniya
    Endo, Itaru
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 670 - 676
  • [27] Live circulating tumor cells as a predictive biomarker of response to neoadjuvant chemoradiotherapy for resectable pancreatic cancer
    Tanemura, Masahiro
    Furukawa, Kenta
    Wakasugi, Masaki
    Kishi, Kentaro
    Urata, Yasuo
    Taniyama, Kiyomi
    Akamatsu, Hiroki
    CANCER RESEARCH, 2016, 76
  • [28] Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer
    Wada, Yukiko
    Okano, Keiichi
    Sato, Kiyotoshi
    Sugimoto, Masahiro
    Shimomura, Ayaka
    Nagao, Mina
    Matsukawa, Hiroyuki
    Ando, Yasuhisa
    Suto, Hironobu
    Oshima, Minoru
    Kondo, Akihiro
    Asano, Eisuke
    Kishino, Takayoshi
    Kumamoto, Kensuke
    Kobara, Hideki
    Kamada, Hideki
    Masaki, Tsutomu
    Soga, Tomoyoshi
    Suzuki, Yasuyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (08) : 879 - 887
  • [29] Role of the tumor microenvironment in pancreatic cancer
    Murakami, Takashi
    Hiroshima, Yukihiko
    Matsuyama, Ryusei
    Homma, Yuki
    Hoffman, Robert M.
    Endo, Itaru
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2019, 3 (02): : 130 - 137
  • [30] Chemotherapy and tumor microenvironment of pancreatic cancer
    Qiaofei Liu
    Quan Liao
    Yupei Zhao
    Cancer Cell International, 17
12345